Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPER: Tranexamic Acid in THA Patients on Rivaroxaban
NCT02403596Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Oct 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in hemorrhage, sponsored by Centre Hospitalier Universitaire de Brest. Started Oct 2015; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02403596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403596.